Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Plos One|May 5, 2012
High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter studyJoana Rolo, Maria Miragaia, Agata Turlej-Rogacka, et al.
Environmental and Molecular Mutagenesis|March 5, 2014
Integrated approach to the in vivo genotoxic effects of a titanium dioxide nanomaterial using LacZ plasmid-based transgenic miceHenriqueta Louro, Ana Tavares, Nádia Vital, et al.
Papillomavirus Research (Amsterdam, Netherlands)|August 5, 2019
High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening programHugo Sousa, Ana Tavares, Carla Campos, et al.
Annals of Work Exposures and Health|December 10, 2024
HBM4EU chromates study: the Portuguese integrated and harmonized study on exposure to hexavalent chromium and related early effectsSusana Viegas, Carla Martins, Edna Ribeiro, et al.
Plos Neglected Tropical Diseases|December 16, 2014
P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infectionJúlio Santos, Elisabete Fernandes, José Alexandre Ferreira, et al.
The AAPS Journal|June 27, 2025
Dissolution of Oral Solid Dosage Formulations: Surrogate Models and Real-time ReleaseMelanie Dumarey, Tessa M Carducci, Matthew J Walworth, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 7, 2016
Phosphate conversion coating reduces the degradation rate and suppresses side effects of metallic magnesium implants in an animal modelMuhammad Imran Rahim, Ana Tavares, Florian Evertz, et al.
Urologic Oncology|June 9, 2020
Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferationCarina Bernardo, Júlio Santos, Céu Costa, et al.
Molecular Oncology|February 4, 2017
Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumoursSofia Cotton, Rita Azevedo, Cristiana Gaiteiro, et al.
Plos One|November 17, 2015
Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted TherapeuticsCéu Costa, Sofia Pereira, Luís Lima, et al.
Pageof 6